Global Patent Index - EP 2978417 A4

EP 2978417 A4 20170301 - COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL

Title (en)

COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL

Title (de)

ZUSAMMENSETZUNG UND VERFAHREN ZUR INDUZIERUNG EPO-VERMITTELTER HÄMOGLOBINEXPRESSION UND MITOCHONDRIALER BIOGENESE IN NICHTHÄMATOPOIETISCHEN ZELLEN

Title (fr)

COMPOSITION ET PROCÉDÉ POUR INDUIRE L'EXPRESSION D'HÉMOGLOBINE MÉDIÉE PAR L'EPO ET LA BIOGÉNÈSE MITOCHONDRIALE DANS UNE CELLULE NON HÉMATOPOÏÉTIQUE

Publication

EP 2978417 A4 20170301 (EN)

Application

EP 13880425 A 20130328

Priority

US 2013034381 W 20130328

Abstract (en)

[origin: WO2014158165A1] A composition for inducing erythropoietin (EPO)-mediated haemoglobin (Hb) expression in a nonhaematopoietic cell of a subject is provided. The composition includes a compound represented by formula (I), wherein R is a glycosyl group; and a pharmaceutical acceptable carrier.

IPC 8 full level

A61K 31/05 (2006.01); A61K 31/045 (2006.01); A61K 31/70 (2006.01); A61K 31/7034 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01)

CPC (source: EP)

A61K 31/7034 (2013.01); A61P 1/04 (2017.12); A61P 3/00 (2017.12); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 7/06 (2017.12); A61P 9/00 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 13/12 (2017.12); A61P 19/00 (2017.12); A61P 21/00 (2017.12); A61P 25/00 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/20 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 43/00 (2017.12)

Citation (search report)

  • [X] US 2009324751 A1 20091231 - WU REY-YUH [TW], et al
  • [X] LI X ET AL: "Tetrahydroxystilbene glucoside attenuates MPP<+>-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 483, no. 1, 8 October 2010 (2010-10-08), pages 1 - 5, XP027243566, ISSN: 0304-3940, [retrieved on 20100826]
  • [X] ZHANG WEI ET AL: "Treatment with 2,3,4',5-tetrahydroxystilbene-2-O-.beta.-D-glucoside in atherosclerosis in rats", ZHONGGUO YAOKE DAXUE XUEBAO - JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, NANJING, CN, vol. 38, no. 3, 1 January 2007 (2007-01-01), pages 261 - 264, XP008119057, ISSN: 1000-5048
  • See references of WO 2014158165A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2014158165 A1 20141002; AU 2013384234 A1 20151015; CA 2907965 A1 20141002; CA 2907965 C 20211207; CN 105188688 A 20151223; EP 2978417 A1 20160203; EP 2978417 A4 20170301; HK 1219871 A1 20170421; JP 2016516745 A 20160609; KR 20150135430 A 20151202

DOCDB simple family (application)

US 2013034381 W 20130328; AU 2013384234 A 20130328; CA 2907965 A 20130328; CN 201380075192 A 20130328; EP 13880425 A 20130328; HK 16107786 A 20160705; JP 2016505443 A 20130328; KR 20157030448 A 20130328